Results 201 to 210 of about 3,004,898 (219)

Reactogenicity and Immunogenicity After a Late Second Dose or a Third Dose of ChAdOx1 nCoV-19 in the UK: A Substudy of Two Randomised Controlled Trials (COV001 and COV002)

Lancet, The, 2021
Pedro M Folegatti, Merryn Voysey, Amy Flaxman   +2 more
exaly  

Dose-Dependent COVID-19 Symptoms

Nature Reviews Microbiology, 2021
Ursula Hofer
exaly  

Perspective: National Cancer Institute Summary Report About Estimated Exposures and Thyroid Doses Received From Iodine 131 in Fallout After Nevada Atmospheric Nuclear Bomb Tests

Ca-A Cancer Journal for Clinicians, 1998
Scott A Hundahl, S A Hundahl
exaly  

Issues With Implementing a High-Quality Lung Cancer Screening Program

Ca-A Cancer Journal for Clinicians, 2014
James L Mulshine, Thomas A D'Amico
exaly  

High-Dose Cytarabine Plus High-Dose Methotrexate Versus High-Dose Methotrexate Alone in Patients With Primary CNS Lymphoma: A Randomised Phase 2 Trial

Lancet, The, 2009
Giuseppe Rossi, Andrés J M Ferreri, Caterina Stelitano   +2 more
exaly  

Double-Dose Versus Standard-Dose Clopidogrel and High-Dose Versus Low-Dose Aspirin in Individuals Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes (CURRENT-OASIS 7): A Randomised Factorial Trial

Lancet, The, 2010
Philippe Gabriel Steg, Harvey D White
exaly  

Randomised Trial of High-Dose Isosorbide Dinitrate Plus Low-Dose Furosemide Versus High-Dose Furosemide Plus Low-Dose Isosorbide Dinitrate in Severe Pulmonary Oedema

Lancet, The, 1998
Gad Cotter, Yaron Moshkovitz
exaly  

Phase I–II Clinical Trial Design: A State-of-the-Art Paradigm for Dose Finding

Annals of Oncology, 2018
Peter F Thall, Mark R Gilbert, Ying Yuan
exaly  

Effects of High-Dose Versus Low-Dose Losartan on Clinical Outcomes in Patients With Heart Failure (HEAAL Study): A Randomised, Double-Blind Trial

Lancet, The, 2009
Ronald D Smith, Helmut Drexler
exaly  

The NHL-15 Protocol for Aggressive Non-Hodgkin's Lymphomas: A Sequential Dose-Dense, Dose-Intense Regimen of Doxorubicin, Vincristine and High-Dose Cyclophosphamide

Annals of Oncology, 2004
J P O'Brien, D J Strauß, D Filippa
exaly